North American Group for New Cancer Treatments
Official title: North American Star Consortium
Funded at University Health Network · NIH-11074688 · Data updated 2026-11-12
This group brings together top cancer centers to find new ways to treat cancer through early stage clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University Health Network NIH-funded |
| Lab location | 1 site (Toronto, Canada) |
| Project start | April 7, 2014 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $1,720,919 |
| NIH project number | 5UM1CA186644-09 |
| Project ID | NIH-11074688 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with various types of cancer who are seeking early-stage experimental treatments may be ideal candidates.
✕Less likely to help
Patients who are not eligible for early-phase clinical trials or whose cancer type is not currently being studied may not receive direct benefit.
What this research studies
This collaborative group brings together leading cancer centers across North America to discover and test new treatments for various cancers. Our goal is to find promising anti-cancer agents and understand how they work in the body, including identifying important biological markers. We conduct early-stage clinical trials, offering patients access to innovative therapies that are still in development. The consortium also focuses on ensuring diverse patient participation and advancing the field through scientific research.
Why it matters
Potential benefit: If successful, this work could lead to new and more effective anti-cancer treatments for patients.
How similar studies have gone: The consortium has a track record of activating numerous early-phase clinical trials and successfully enrolling patients in previous iterations.
Where this research is happening
-
University Health Network
Toronto, Canada Active
Researchers
- Principal investigator: Bedard, Philippe — University Health Network
- Study coordinator: Bedard, Philippe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.